Effect of Finerenone in IgA Nephropathy

NCT06580288 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: Finerenone
DRUG: Placebo

Sponsor

Zhejiang University